(Total Views: 471)
Posted On: 08/16/2020 4:31:21 PM
Post# of 148987
With Leronlimabs safety Profile would we just need
To be slightly better than than/placebo SOC? Why would we need to show huge difference? If we out perform it by statistically by 10% isn’t that enough? Especially that covid drugs are in short supply and FDA needs multiple therapeutics to fight against covid-19
To be slightly better than than/placebo SOC? Why would we need to show huge difference? If we out perform it by statistically by 10% isn’t that enough? Especially that covid drugs are in short supply and FDA needs multiple therapeutics to fight against covid-19
(3)
(0)Scroll down for more posts ▼
